| Issue |
Section |
Title |
File |
| Vol 78, No 2 (2003) |
Editorial |
New hypolipidemic drugs from the group of reductase inhibitors GMG-CoA |
|
| Vol 78, No 10 (2003) |
Editorial |
Multiple molecular-genetic defects in a female with mixed hyperlipoproteinemia and earlyischemic heart disease |
|
| Vol 79, No 8 (2004) |
Editorial |
Experimental and clinical assessment of antioxidant efficacy of multicomponent antioxidant medication |
|
| Vol 81, No 5 (2009) |
Editorial |
Atherosclerosis: disputable and unsolved problems in the first decade of the XXI century |
|
| Vol 81, No 9 (2009) |
Editorial |
Familial hypercholesterolemia in Russia: genetic and phenotypic characteristics |
|
| Vol 81, No 9 (2009) |
Editorial |
Treatment of patients with hypertriglyceridemia |
|
| Vol 82, No 4 (2010) |
Editorial |
Diagnosis of moderate and high hypertriglyceridemia in patients in polyclinic practice: primary and secondary lipid metabolic disturbances |
|
| Vol 82, No 8 (2010) |
Editorial |
Determination of the levels of brain natriuretic peptide and its N-terminal fragment for the evaluation of the efficiency of renal replacement therapy modalities in patients with decompensated chronic heart failure |
|
| Vol 83, No 9 (2011) |
Editorial |
Relationship between a concentration of lipoprotein-associated secretory phospholipase A2 and markers of subclinical atherosclerotic lesion of arterial wall in patients with low and moderate risk by SCORE scale |
|
| Vol 84, No 9 (2012) |
Editorial |
Trends in the risk factors and signs of subclinical atherosclerosis in subjects at low and moderate risk according to the SCORE scale in different medical management tactics: Two-year follow-up results |
|
| Vol 86, No 12 (2014) |
Editorial |
Hypolipidemic and pleiotropic effects of a combination of simvastatin and ezetimibe in patients with different types of hyperlipidemia |
|
| Vol 90, No 9 (2018) |
Editorial |
The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease |
(Rus)
|
